• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Exploring a novel molecular pathway that underlies cerebellar contribution to autism spectrum disorder

Research Project

Project/Area Number 23K14826
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 52030:Psychiatry-related
Research InstitutionTokai University

Principal Investigator

モハメド ダルウィシュ  東海大学, 医学部, 奨励研究員 (60938934)

Project Period (FY) 2023-04-01 – 2025-03-31
Project Status Granted (Fiscal Year 2023)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2024: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2023: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
KeywordsNeurotropic factors / cerebellum development / ASD / Cerebellum
Outline of Research at the Start

The cerebellum has been involved in neurodevelopmental disorders such as autism spectrum disorders (ASD). However, the molecular mechanism underlying cerebellar development/function and its implication in ASD are not fully understood. We identified a novel neurotropic factor as a potential key molecule for cerebellar development and ASD. I will use mouse genetics, together with molecular, electrophysiological, and behavioral approaches to uncover a novel molecular pathway that underlies cerebellar development and its involvement in ASD pathophysiology.

Outline of Annual Research Achievements

In the first fiscal year, I aimed to elucidate the receptor and signaling pathway of NDNF that work together to maintain proper brain development. To identify NDNF receptors and other binding partners, I performed co-immunoprecipitation-coupled mass spectrometry from HA-tagged NDNF mice brain and identified potential receptor and downstream signaling pathway for NDNF. Indeed, I confirmed this pathway using westernblot analysis. In addition, we discovered that the NDNF undergoes processing and cleavge into a potentially more potent form. Using in vitro experiments, this cleaved form showed superior effect compared to full-length NDNF.

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

I think that the progress during the first year was going well becasue we identified a novel signaling patwhay through NDNF that underlie brain development and function. In addition, we identified a potential active form of NDNF which could have a great therapeutic potential for treating neurodevelopmental disorders.

Strategy for Future Research Activity

In the next year, I plan to investigate whether NDNF receptor is involved in cerebellum development and the pathophysiology of neurodevelopmental disorders, I will knockout the receptor in the cerebellum using virus-based in vivo genome editing and compare morphological and behavioral characteristics to those of Ndnf KO mice. Next, I will investigate whether activating NDNF signaling pathway restores cerebellum function in Ndnf KO mice to confirm causality between NDNF signaling pathways and brain development.
Besides, I aim to check the theraputic potential of NDNF in treating neurodevelopmental disorders. I will inject the cleaved and full length peptide into the cerebellum of neonatal Ndnf KO mice to investigate its therapeutic effect in preventing neurodevelopmental phenotypes.

Report

(1 results)
  • 2023 Research-status Report
  • Research Products

    (2 results)

All 2023

All Presentation (2 results)

  • [Presentation] Exploring a novel molecular pathway underlies cerebellar development and autism spectrum disorder2023

    • Author(s)
      Mohamed Darwish, Yoko Iijima, Takatoshi Iijima.
    • Organizer
      The 64th Annual Meeting of the Japanese Society of Neuropathology /The 66th Annual Meeting of the Japanese Society of Neurochemistry.
    • Related Report
      2023 Research-status Report
  • [Presentation] Exploring a novel molecular pathway underlies cerebellar development and autism spectrum disorder2023

    • Author(s)
      Mohamed Darwish, Yoko Iijima, Takatoshi Iijima.
    • Organizer
      The 44th Annual Meeting of the Japanese Neuroscience Society.
    • Related Report
      2023 Research-status Report

URL: 

Published: 2023-04-13   Modified: 2024-12-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi